A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023.
Canopy Growth Corporation (CGC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q4
including a $27.5 million deficit in 2025Q4, and maintains a precarious liquidity position with cash reserves declining to $364.7 million.
Canopy Growth Corporation (CGC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Canopy Growth Corporation (CGC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 15, 2026 | $0.17vs $0.06-183.3% | $51Mvs $53M-4.1% |
| Q2 2026 | May 29, 2026 | $0.94vs $0.06-1466.7% | —vs $53M |
| Q1 2026 | Feb 6, 2026 | $0.13vs $0.04-218.6% | $54Mvs $52M+5.2% |
| Q4 2025 | Nov 7, 2025 | $0.01vs $0.11+90.9% | $48Mvs $51M-6.4% |
Recent stock market news and headlines for Canopy Growth Corporation (CGC)
A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023.
As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.
While the analyst backs his bull case with estimates and facts, it's hard to envision triple-digit percentage gains for this Canada-based cannabis stock. Even if you're bullish on the U.S. legalization trend, it's smarter to stick with marijuana stocks that have stronger fundamentals.
Canopy Growth Corporation (CGC) closed at $0.95 in the latest trading session, marking a -4.45% move from the prior day.

While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.

Key metrics vs top competitors for Canopy Growth Corporation (CGC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.95 | $365.74M | -1.53 | 5.8% | -92.38% | -44.38% | — | |
| $2.67 | $165.39M | -1.77 | -6.37% | -24.14% | -13.4% | — | |
| $4.31 | $502.21M | -0.13 | 4.84% | -252.55% | -136.55% | — | |
| $2.75 | $1.03B | -112.24 | 64.4% | -0.98% | -0.18% | — | |
| $0.97 | $136.23M | -9.82 | 16.42% | -9.7% | -6.76% | — | |
| $136.88 | $23.38B | 14.24 | -10.47% | 20.14% | 22.3% | — |
Canopy Growth Corporation (CGC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Canopy Growth Corporation (CGC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jun 15, 2026·SEC
May 27, 2026·SEC
May 15, 2026·SEC
Get notified when CGC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Canopy Growth Corporation (CGC) stock FAQ — growth, dividends, profitability & financials explained
Canopy Growth Corporation (CGC) reported $312.3M in revenue for fiscal year 2025. This represents a 56892786% increase from $0.0M in 2009.
Canopy Growth Corporation (CGC) grew revenue by 5.8% over the past year. This is steady growth.
Canopy Growth Corporation (CGC) reported a net loss of $286.2M for fiscal year 2025.
Canopy Growth Corporation (CGC) has a return on equity (ROE) of -44.4%. Negative ROE indicates the company is unprofitable.
Canopy Growth Corporation (CGC) had negative free cash flow of $76.9M in fiscal year 2025, likely due to heavy capital investments.